Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allogen Biologics
United Statesallogenbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Allogen Biologics, a wholly owned subsidiary of Therapeutic Solutions International, provides cellular manufacturing capabilities and produced the JadiCell master cell bank for "Right to Try" applications and ongoing Phase III clinical trials in acute respiratory distress syndrome (ARDS). There is limited public information on additional clinical results or breadth of programs[3][9].
- Therapeutic areas
- PulmonologyOther
- Modalities
- Cell therapy
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Allogen Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allogen Biologics.